Dan Huang
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- RNA modifications and cancer
- Gut microbiota and health
- Cancer-related gene regulation
- Epigenetics and DNA Methylation
Papers in
-
- RNA modifications and cancer 5
- Gut microbiota and health 2
-
- Ferroptosis and cancer prognosis 3
- Chronic Obstructive Pulmonary Disease (COPD) Research 3
- Co-authors
- Jun Yu (8 shared papers)Wei Kang (3 shared papers)Huarong Chen (6 shared papers)Jianning Zhai (3 shared papers)Cong Liang (3 shared papers)Yasi Pan (3 shared papers)Weixin Liu (4 shared papers)Yanqiang Ding (3 shared papers)
In The Last Decade
Dan Huang
56 papers receiving 1.4k citations
Dan Huang's Hit Papers
Peers
Comparison fields: 5 of 114
- Cancer Research 199
- Molecular Biology 712
- Oncology 188
- Immunology 111
- Biotechnology 47
Countries citing papers authored by Dan Huang
This map shows the geographic impact of Dan Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Huang more than expected).
Fields of papers citing papers by Dan Huang
This network shows the impact of papers produced by Dan Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Huang. The network helps show where Dan Huang may publish in the future.
Co-authors
The 25 scholars most cited alongside Dan Huang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 195 | |
| 2 | METTL3 Inhibits Antitumor Immunity by Targeting m6A-BHLHE41-CXCL1/CXCR2 Axis to Promote Colorectal Cancer Hit paper breakdown → | 2022 | 188 |
| 3 | Targeting m 6 A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer Hit paper breakdown → | 2023 | 173 |
| 4 | 2023 | 100 | |
| 5 | Potential gastrointestinal tumor suppressor locus at the 3p14.2 FRA3B site identified by homozygous deletions in tumor cell lines. | 1996 | 99 |
| 6 | Peptostreptococcus anaerobius mediates anti-PD1 therapy resistance and exacerbates colorectal cancer via myeloid-derived suppressor cells in mice Hit paper breakdown → | 2024 | 65 |
| 7 | 2018 | 54 | |
| 8 | 2018 | 35 | |
| 9 | 2017 | 32 | |
| 10 | 2020 | 30 | |
| 11 | 2021 | 30 | |
| 12 | 2016 | 30 | |
| 13 | 2021 | 25 | |
| 14 | 2019 | 23 | |
| 15 | 2019 | 23 | |
| 16 | 2020 | 23 | |
| 17 | 2017 | 22 | |
| 18 | 2022 | 19 | |
| 19 | 2021 | 18 | |
| 20 | 2019 | 16 |
About Dan Huang
Dan Huang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Physiology and Oncology, having authored 59 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (5 papers), Adipose Tissue and Metabolism (3 papers), Ferroptosis and cancer prognosis (3 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers), interferon and immune responses (2 papers), Gut microbiota and health (2 papers) and Nutrition and Health in Aging (2 papers). The work is most often cited by research in Cancer Research (199 citations), Molecular Biology (712 citations), Oncology (188 citations), Immunology (111 citations) and Biotechnology (47 citations). Dan Huang has collaborated with scholars based in China, Hong Kong and Germany. Frequent co-authors include Jun Yu, Wei Kang, Huarong Chen, Jianning Zhai, Cong Liang, Yasi Pan, Weixin Liu, Yanqiang Ding, Chi Chun Wong and Hongyan Gou. Their work appears in journals such as Frontiers in Pharmacology, Gastroenterology, Genes, Annals of Palliative Medicine and Nature Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.